InKine Pharmaceutical Company, Inc. (Nasdaq: INKP) and Salix Pharmaceuticals, Ltd. (Nasdaq: SLXP) announced that earlier today the shareholders of...
InKine Pharmaceutical Company, Inc. (Nasdaq: INKP) today announced that Institutional Shareholder Services (ISS), the nation's leading independent...
InKine Pharmaceutical Company, Inc. (Nasdaq: INKP): ? Highlights ? -- Entered into a definitive merger agreement with Salix Pharmaceuticals...
InKine Pharmaceutical Company, Inc. (Nasdaq: INKP) today announced that seven abstracts with data from clinical studies of the Company's...
Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) and InKine Pharmaceutical Company, Inc. (NASDAQ: INKP) announced today that the two companies have...
InKine Pharmaceutical Company, Inc. (Nasdaq:INKP) today announced that the Philadelphia Court of Common Pleas entered a final judgment order...
InKine Pharmaceutical Company, Inc. (NASDAQ:INKP): -Highlights- ? -- Completed Phase III Clinical Study and Submitted a New Drug Application...
InKine Pharmaceutical Company, Inc. (Nasdaq: INKP) today announced that on April 29, 2005 the Company submitted an electronic New Drug Application...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.